Unilever (UL) 6-K 26 Jul 24 2024 Q2 Current report (foreign) Financial data

Cover page

Cover page	6 Months Ended
	Jun. 30, 2024
Cover [Abstract]
Document Type	6-K
Entity Registrant Name	UNILEVER PLC
Amendment Flag	false
Entity Central Index Key	0000217410
Current Fiscal Year End Date	--12-31
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2

Consolidated income statement

Consolidated income statement - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Profit or loss [abstract]
Turnover	€ 31,117	€ 30,428
Operating profit	5,948	5,516
Net finance costs	(358)	(259)
Pensions and similar obligations	35	50
Finance income	217	208
Finance costs	(610)	(517)
Net monetary gain/(loss) arising from hyperinflationary economies	(157)	(98)
Share of net profit/(loss) of joint ventures and associates	138	118
Other income/(loss) from non-current investments and associates	(5)	(10)
Profit before taxation	5,566	5,267
Taxation	(1,550)	(1,385)
Net profit	4,016	3,882
Attributable to:
Non-controlling interests	315	334
Shareholders’ equity	€ 3,701	€ 3,548
Earnings per share
Basic earnings per share (in euros per share)	€ 1.48	€ 1.41
Diluted earnings per share (in euros per share)	€ 1.47	€ 1.40

Consolidated statement of compr

Consolidated statement of comprehensive income - EUR (€) € in Millions		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Statement of comprehensive income [abstract]
Net profit		€ 4,016	€ 3,882
Items that will not be reclassified to profit or loss, net of tax:
Gains/(losses) on equity instruments measured at fair value through other comprehensive income		31	(34)
Remeasurement of defined benefit pension plans		201	(47)
Items that may be reclassified subsequently to profit or loss, net of tax:
Gains/(losses) on cash flow hedges		58	(22)
Currency retranslation gains/(losses)	[1]	756	(555)
Total comprehensive income		5,062	3,224
Attributable to:
Non-controlling interests		379	284
Shareholders’ equity		€ 4,683	€ 2,940
[1]2024 includes a hyperinflation adjustment of €680 million (2023: €247 million) in relation to Argentina and Turkey.

Consolidated statement of chang

Consolidated statement of changes in equity - EUR (€) € in Millions		Total	Total	Called up share capital	Share premium account	Unification reserve	Other reserves	Retained profit	Non- controlling interest
Equity at beginning of period at Dec. 31, 2022		€ 21,701	€ 19,021	€ 92	€ 52,844	€ (73,364)	€ (10,804)	€ 50,253	€ 2,680
Profit or loss for the period		3,882	3,548					3,548	334
Gains/(losses) on:
Equity instruments		(34)	(33)				(33)		(1)
Cash flow hedges		(22)	(22)				(22)
Remeasurement of defined benefit pension plans		(47)	(48)					(48)	1
Currency retranslation gains/(losses)	[1]	(555)	(505)				(736)	231	(50)
Total comprehensive income		3,224	2,940				(791)	3,731	284
Dividends on ordinary capital		(2,172)	(2,172)					(2,172)
Repurchase of shares	[2]	(753)	(753)				(753)
Movements in treasury shares	[3]	1	1				69	(68)
Share-based payment credit	[4]	159	159					159
Dividends paid to non-controlling interests		(276)							(276)
Hedging gain/(loss) transferred to non-financial assets		78	78				78
Other movements in equity(e)		(41)	(17)				5	(22)	(24)
Equity at end of period at Jun. 30, 2023		21,921	19,257	92	52,844	(73,364)	(12,196)	51,881	2,664
Equity at beginning of period at Dec. 31, 2023		20,764	18,102	88	52,844	(73,364)	(8,518)	47,052	2,662
Profit or loss for the period		4,016	3,701					3,701	315
Gains/(losses) on:
Equity instruments		31	31				31
Cash flow hedges		58	58				58
Remeasurement of defined benefit pension plans		201	200					200	1
Currency retranslation gains/(losses)	[1]	756	693				10	683	63
Total comprehensive income		5,062	4,683				99	4,584	379
Dividends on ordinary capital		(2,136)	(2,136)					(2,136)
Repurchase of shares	[2]	(375)	(375)				(375)
Movements in treasury shares	[3]	(75)	(75)				25	(100)
Share-based payment credit	[4]	164	164					164
Dividends paid to non-controlling interests		(354)							(354)
Hedging gain/(loss) transferred to non-financial assets		1	1				1
Other movements in equity(e)	[5]	(28)	(56)				(59)	3	28
Equity at end of period at Jun. 30, 2024		€ 23,023	€ 20,308	€ 88	€ 52,844	€ (73,364)	€ (8,827)	€ 49,567	€ 2,715
[1]2024 includes a hyperinflation adjustment of €680 million (2023: €247 million) in relation to Argentina and Turkey.[2]Repurchase of shares reflects the cost of acquiring ordinary shares as part of the share buyback program announced on 10 February 2022 and 8 February 2024.[3]Includes purchases and sales of treasury shares, other than the share buyback programme and the transfer from treasury shares to retained profit of share-settled schemes arising from prior years and differences between purchase and grant price of share awards.[4]The share-based payment credit relates to the non-cash charge recorded against operating profit in respect of the fair value of share options and awards granted to employees.[5]Includes the following items related to the acquisition of K18: €(59) million non-controlling interest purchase option in other reserves and €28 million non-controlling interest recognised on acquisition.

Consolidated statement of cha_2

Consolidated statement of changes in equity (Parenthetical) - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Hyperinflation adjustment	€ 680	€ 247
Other reserves
Increase (decrease) through acquisition of subsidiary, equity	(59)
Non- controlling interest
Increase (decrease) through acquisition of subsidiary, equity	€ 28

Consolidated balance sheet

Consolidated balance sheet - EUR (€) € in Millions	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Non-current assets
Goodwill	€ 22,009	€ 21,109	€ 21,299
Intangible assets	19,092	18,357	18,664
Property, plant and equipment	11,098	10,707	10,590
Pension asset for funded schemes in surplus	3,837	3,781	4,244
Deferred tax assets	1,055	1,113	1,084
Financial assets	1,506	1,386	1,220
Other non-current assets	1,014	911	952
Total non-current assets	59,611	57,364	58,053
Current assets
Inventories	5,621	5,119	5,668
Trade and other current receivables	7,999	5,775	8,046
Current tax assets	168	427	254
Cash and cash equivalents	4,970	4,159	4,994
Other financial assets	1,445	1,731	1,376
Assets held for sale	18	691	18
Total current assets	20,221	17,902	20,356
Total assets	79,832	75,266	78,409
Current liabilities
Financial liabilities	7,643	5,087	6,715
Trade payables and other current liabilities	17,209	16,857	17,367
Current tax liabilities	721	851	891
Provisions	557	537	634
Liabilities held for sale	0	175	0
Total current liabilities	26,130	23,507	25,607
Non-current liabilities
Financial liabilities	24,011	24,535	23,993
Non-current tax liabilities	494	384	280
Pensions and post-retirement healthcare liabilities:
Funded schemes in deficit	144	351	431
Unfunded schemes	1,002	1,029	1,040
Provisions	581	563	547
Deferred tax liabilities	4,263	3,995	4,410
Other non-current liabilities	184	138	180
Total non current liabilities	30,679	30,995	30,881
Total liabilities	56,809	54,502	56,488
Equity
Shareholders’ equity	20,308	18,102	19,257
Non-controlling interests	2,715	2,662	2,664
Total equity	23,023	20,764	21,921
Total liabilities and equity	€ 79,832	€ 75,266	€ 78,409

Consolidated cash flow statemen

Consolidated cash flow statement - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from (used in) operating activities [abstract]
Net profit	€ 4,016	€ 3,882
Taxation	1,550	1,385
Share of net (profit)/loss of joint ventures/associates and other (income)/loss from non-current investments and associates	(133)	(108)
Net monetary (gain)/loss arising from hyperinflationary economies	157	98
Net finance costs	358	259
Operating profit	5,948	5,516
Depreciation, amortisation and impairment	794	754
Changes in working capital	(2,127)	(1,331)
Inventories	(435)	100
Trade and other receivables	(2,159)	(1,229)
Trade payables and other liabilities	467	(202)
Pensions and similar obligations less payments	36	(103)
Provisions less payments	35	(122)
Elimination of (profits)/losses on disposals	(135)	(507)
Non-cash charge for share-based compensation	164	159
Other adjustments	(36)	11
Cash flow from operating activities	4,679	4,377
Income tax paid	(1,315)	(1,011)
Net cash flow from operating activities	3,364	3,366
Cash flows from (used in) investing activities [abstract]
Interest received	189	139
Purchase of intangible assets	(98)	(92)
Purchase of property, plant and equipment	(617)	(478)
Disposal of property, plant and equipment	5	22
Acquisition of businesses and investments in joint ventures and associates	(797)	(67)
Disposal of businesses, joint ventures and associates	489	419
Acquisition of other non-current investments	(108)	(202)
Disposal of other non-current investments	47	37
Dividends from joint ventures, associates and other non-current investments	94	98
(Purchase)/sale of financial assets	404	(76)
Net cash flow (used in)/from investing activities	(392)	(200)
Cash flows from (used in) financing activities [abstract]
Dividends paid on ordinary share capital	(2,136)	(2,202)
Interest paid	(691)	(503)
Net change in short-term borrowings	850	158
Additional financial liabilities	3,016	3,511
Repayment of financial liabilities	(2,297)	(2,242)
Capital element of lease rental payments	(191)	(197)
Repurchase of shares	(375)	(753)
Other financing activities	(330)	(261)
Net cash flow (used in)/from financing activities	(2,154)	(2,489)
Net increase/(decrease) in cash and cash equivalents	818	677
Cash and cash equivalents at the beginning of the period	4,045	4,225
Effect of foreign exchange rate changes	(9)	(32)
Cash and cash equivalents at the end of the period	€ 4,854	€ 4,870

Accounting information and poli

Accounting information and policies	6 Months Ended
	Jun. 30, 2024
Disclosure Of Summary Of Significant Accounting Policies [Abstract]
Accounting information and policies	1. Accounting information and policies These condensed consolidated financial statements are prepared in accordance with IAS 34 'Interim Financial Reporting' as issued by the International Accounting Standards Board (IASB) and as adopted for use in the UK. As required by the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the condensed consolidated financial statements have been prepared applying the accounting policies and presentation that were applied in the preparation of the Group’s published consolidated financial statements for the year ended 31 December 2023. In preparing these condensed consolidated financial statements, judgements and estimates that affect the application of accounting policies used by management have remained consistent with those applied in the consolidated financial statements for the year ended 31 December 2023. Management have produced forecasts which have been modelled for different plausible scenarios. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2024 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these condensed consolidated financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year condensed consolidated financial statements. The condensed consolidated financial statements are shown at current exchange rates with year-on-year changes shown to facilitate comparison. The consolidated income statement on page 19 19 20 22 21 The condensed consolidated financial statements attached do not constitute the full financial statements within the meaning of section 434 of the UK Companies Act 2006. The comparative figures for the financial year ended 31 December 2023 are not Unilever PLC’s statutory accounts for that financial year. The annual financial statements of the Group are prepared in accordance with international financial reporting standards (IFRS) as issued by the International Accounting Standards Board (IASB) and UK adopted international accounting standards and in accordance with the requirements of the UK Companies Act 2006. Recent accounting developments adopted by the Group The Group adopted the amendments to IAS 7 and IFRS 7 “Supplier Finance Arrangements” from reporting period beginning 1 January 2024. The amendments introduce additional disclosure requirements for companies that enter supplier finance arrangements. The company will apply these amendments in the 2024 Annual Report. All other standards or amendments to the standards that have been issued by the IASB and were effective 1 January 2024 were not applicable or material to Unilever.

Segment information - Business

Segment information - Business Groups	6 Months Ended
	Jun. 30, 2024
Disclosure of operating segments [abstract]
Segment information - Business Groups	2. Segment information - Business Groups Second Quarter Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2023 3,143 3,519 3,057 3,260 2,760 15,739 2024 3,343 3,531 3,113 3,289 2,815 16,091 Change (%) 6.3 0.3 1.8 0.9 2.0 2.2 First Half Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2023 6,225 6,911 6,205 6,601 4,486 30,428 2024 6,539 6,953 6,328 6,687 4,610 31,117 Change (%) 5.1 0.6 2.0 1.3 2.8 2.3 Operating profit (€ million) 2023 1,237 1,691 731 1,213 644 5,516 2024 1,269 1,696 963 1,423 597 5,948 Underlying operating profit (€ million) 2023 1,179 1,381 763 1,214 671 5,208 2024 1,305 1,601 1,031 1,491 672 6,100 Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components. Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for the purpose of making decisions about allocating resources and assessing performance of segments.

Segment information - Geographi

Segment information - Geographical area	6 Months Ended
	Jun. 30, 2024
Disclosure of operating segments [abstract]
Segment information - Geographical area	3. Segment information - Geographical area Second Quarter Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2023 6,699 5,700 3,340 15,739 2024 6,732 5,924 3,435 16,091 Change (%) 0.5 3.9 2.9 2.2 First Half Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2023 13,421 10,956 6,051 30,428 2024 13,370 11,463 6,284 31,117 Change (%) (0.4) 4.6 3.8 2.3

Taxation

Taxation	6 Months Ended
	Jun. 30, 2024
Income taxes paid (refund) [abstract]
Taxation	4. Taxation The effective tax rate for the first half is 28.6% compared with 26.9% in 2023. The tax rate is calculated by dividing the tax charge by pre-tax profit excluding the contribution of joint ventures and associates. Tax effects of components of other comprehensive income were as follows: First half 2024 2023 € million Before tax Tax (charge)/credit After tax Before tax Tax (charge)/credit After tax Gains/(losses) on: Equity instruments at fair value through other comprehensive income 31 – 31 (34) – (34) Cash flow hedges 63 (5) 58 (20) (2) (22) Remeasurements of defined benefit pension plans 242 (41) 201 (90) 43 (47) Currency retranslation gains/(losses) 772 (16) 756 (535) (20) (555) Other comprehensive income 1,108 (62) 1,046 (679) 21 (658)

Earnings per share

Earnings per share	6 Months Ended
	Jun. 30, 2024
Earnings per share [abstract]
Earnings per share	5. Earnings per share The earnings per share calculations are based on the average number of share units representing the ordinary shares of PLC in issue during the period, less the average number of shares held as treasury shares. In calculating diluted earnings per share, a number of adjustments are made to the number of shares, principally the exercise of share plans by employees. Earnings per share for total operations for the six months were calculated as follows: First Half 2024 2023 EPS – Basic Net profit attributable to shareholders’ equity (€ million) 3,701 3,548 Average number of shares (millions of share units) 2,499.9 2,523.9 EPS – basic (€) 1.48 1.41 EPS – Diluted Net profit attributable to shareholders’ equity (€ million) 3,701 3,548 Adjusted average number of shares (millions of share units) 2,511.0 2,536.8 EPS – diluted (€) 1.47 1.40 During the period the following movements in shares have taken place: Millions Number of shares at 31 December 2023 (net of treasury shares) 2,499.0 Shares repurchased under the share buyback programme (7.3) Net movements in shares under incentive schemes 3.7 Number of shares at 30 June 2024 (net of treasury shares) 2,495.4

Acquisitions and disposals

Acquisitions and disposals	6 Months Ended
	Jun. 30, 2024
Disclosure of detailed information about business combination [abstract]
Acquisitions and disposals	6. Acquisitions and disposals In the first half of 2024, the Group completed the following business acquisitions and disposals: Deal completion date Acquired/disposed business 1 February 2024 Acquired 91.88% of K18, a U.S. based premium hair care brand. The acquisition complements Unilever’s existing Beauty and Wellbeing portfolio, with a range of high-quality, hair care products. 1 June 2024 Sold Elida Beauty to Yellow Wood Partners LLC. Elida Beauty comprises more than 20 beauty and personal care brands, such as Q-Tips, Caress, Timotei and TIGI. On 1 June 2024, Unilever completed the disposal of the Elida Beauty business to Yellow Wood Partners LLC for consideration of €588 million. Profit on this disposal is €151 million, recognised as a non-underlying item.

Share buyback

Share buyback	6 Months Ended
	Jun. 30, 2024
Share Buyback [Abstract]
Share buyback	7. Share buyback On 8 February 2024, Unilever PLC announced a programme to buy back shares with an aggregate market value equivalent of up to €1.5 billion, to be completed during 2024. On 17 May 2024, Unilever announced the commencement of the first tranche of the buyback programme (the “First Tranche”) for an aggregate market value equivalent of up to €850 million. As at 30 June 2024, 7,315,036 shares had been purchased for €375 million, which will be held as Treasury stock until cancellation.

Financial instruments

Financial instruments	6 Months Ended
	Jun. 30, 2024
Disclosure of detailed information about financial instruments [abstract]
Financial instruments	8. Financial instruments The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2024 and 2023. The Group’s cash resources and 30 June 2024 31 December 2023 30 June 2023 Current Non-current Total Current Non-current Total Current Non-current Total Cash and cash equivalents Cash at bank and in hand 3,601 – 3,601 2,862 – 2,862 2,790 – 2,790 Short-term deposits (a) 981 – 981 1,181 – 1,181 1,804 – 1,804 Other cash equivalents (b) 388 – 388 116 – 116 400 – 400 4,970 – 4,970 4,159 – 4,159 4,994 – 4,994 Other financial assets Financial assets at amortised cost (c) 835 560 1,395 961 454 1,415 727 352 1,079 Financial assets at fair value through other comprehensive income (d) 61 525 586 151 458 609 – 438 438 Financial assets at fair value through profit or loss: Derivatives 79 39 118 37 75 112 36 31 67 Other (e) 470 382 852 582 399 981 613 399 1,012 1,445 1,506 2,951 1,731 1,386 3,117 1,376 1,220 2,596 Total financial assets (f) 6,415 1,506 7,921 5,890 1,386 7,276 6,370 1,220 7,590 (a) Short-term deposits typically have maturity of up to 3 months. (b) Other cash equivalents include investments in overnight funds and marketable securities. (c) Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months excluding deposits which are part of a recognised cash management process and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposits of €212 million (31 December 2023: €227 million; 30 June 2023: €228 million). (d) Included within non-current financial assets at fair value through other comprehensive income are equity investments. (e) Other financial assets at fair value through profit or loss include money market funds, marketable securities, other capital market instruments (f) Financial assets exclude trade and other current receivables. Notes to the condensed consolidated financial statements (unaudited) 8. Financial instruments (continued) The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category. € million Fair value Carrying amount As at 30 June 2024 As at 31 December 2023 As at 30 June 2023 As at 30 June 2024 As at 31 December 2023 As at 30 June 2023 Financial assets Cash and cash equivalents 4,970 4,159 4,994 4,970 4,159 4,994 Financial assets at amortised cost 1,395 1,415 1,079 1,395 1,415 1,079 Financial assets at fair value through other comprehensive income 586 609 438 586 609 438 Financial assets at fair value through profit and loss: Derivatives 118 112 67 118 112 67 Other 852 981 1,012 852 981 1,012 7,921 7,276 7,590 7,921 7,276 7,590 Financial liabilities Bank loans and overdrafts (460) (506) (606) (460) (506) (606) Bonds and other loans (27,836) (26,112) (26,265) (28,729) (26,692) (27,599) Lease liabilities (1,358) (1,395) (1,428) (1,358) (1,395) (1,428) Derivatives (537) (494) (618) (537) (494) (618) Other financial liabilities (570) (535) (457) (570) (535) (457) (30,761) (29,042) (29,374) (31,654) (29,622) (30,708) € million As at 30 June 2024 As at 31 December 2023 As at 30 June 2023 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets at fair value Financial assets at fair value through other comprehensive income 70 4 512 163 4 442 14 3 421 Financial assets at fair value through profit or loss: Derivatives (a) – 192 – – 149 – – 142 – Other 470 – 382 582 – 399 613 – 399 Liabilities at fair value Derivatives (b) – (586) – – (559) – – (718) – Contingent consideration – – (8) – – (157) – – (123) (a) Includes €74 million (31 December 2023: €37 million; 30 June 2023: €75 million) derivatives, reported within trade receivables, that hedge trading activities. (b) Includes €(49) million (31 December 2023: €(65) million; 30 June 2023: €(100) million) derivatives, reported within trade creditors, that hedge trading activities. There were no significant changes in classification of fair value of financial assets and financial liabilities since The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature. The fair value of financial assets and financial liabilities (excluding listed bonds) is considered to be same as the carrying amount for 2024 and 2023. Calculation of fair values The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values are consistent with those used in the year ended 31 December 2023.

Dividends

Dividends	6 Months Ended
	Jun. 30, 2024
Dividends [Abstract]
Dividends	9. Dividends The Board has declared a quarterly interim dividend for Q2 2024 of £0.3696 per Unilever PLC ordinary share or €0.4396 per Unilever PLC ordinary share at the applicable exchange rate issued by WM/Reuters on 23 July 2024. The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date: Per Unilever PLC ordinary share (traded on the London Stock Exchange): £0.3696 Per Unilever PLC ordinary share (traded on Euronext in Amsterdam): €0.4396 Per Unilever PLC American Depositary Receipt: US$0.4773 The euro and US dollar amounts above have been determined using the applicable exchange rates issued by WM/Reuters on 23 July 2024. US dollar cheques for the quarterly interim dividend will be mailed on 6 September 2024 to holders of record at the close of business on 9 August 2024. The quarterly dividend calendar for the remainder of 2024 will be as follows: Announcement Date Ex-Dividend Date Record Date Payment Date Q2 2024 Dividend 25 July 2024 08 August 2024 09 August 2024 06 September 2024 Q3 2024 Dividend 24 October 2024 07 November 2024 08 November 2024 06 December 2024

Events after the balance sheet

Events after the balance sheet date	6 Months Ended
	Jun. 30, 2024
Disclosure of non-adjusting events after reporting period [abstract]
Events after the balance sheet date	10. Events after the balance sheet date There are no material post balance sheet events other than those mentioned elsewhere in this report.

Accounting information and po_2

Accounting information and policies (Policies)	6 Months Ended
	Jun. 30, 2024
Disclosure Of Summary Of Significant Accounting Policies [Abstract]
Basis of preparation	These condensed consolidated financial statements are prepared in accordance with IAS 34 'Interim Financial Reporting' as issued by the International Accounting Standards Board (IASB) and as adopted for use in the UK. As required by the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the condensed consolidated financial statements have been prepared applying the accounting policies and presentation that were applied in the preparation of the Group’s published consolidated financial statements for the year ended 31 December 2023. In preparing these condensed consolidated financial statements, judgements and estimates that affect the application of accounting policies used by management have remained consistent with those applied in the consolidated financial statements for the year ended 31 December 2023. Management have produced forecasts which have been modelled for different plausible scenarios. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2024 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these condensed consolidated financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year condensed consolidated financial statements. The condensed consolidated financial statements are shown at current exchange rates with year-on-year changes shown to facilitate comparison. The consolidated income statement on page 19 19 20 22 21
New acounting standards	Recent accounting developments adopted by the Group The Group adopted the amendments to IAS 7 and IFRS 7 “Supplier Finance Arrangements” from reporting period beginning 1 January 2024. The amendments introduce additional disclosure requirements for companies that enter supplier finance arrangements. The company will apply these amendments in the 2024 Annual Report. All other standards or amendments to the standards that have been issued by the IASB and were effective 1 January 2024 were not applicable or material to Unilever.

Segment information - Busines_2

Segment information - Business Groups (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure of operating segments [abstract]
Summary of Operating Results by Reportable Segments	Second Quarter Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2023 3,143 3,519 3,057 3,260 2,760 15,739 2024 3,343 3,531 3,113 3,289 2,815 16,091 Change (%) 6.3 0.3 1.8 0.9 2.0 2.2 First Half Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2023 6,225 6,911 6,205 6,601 4,486 30,428 2024 6,539 6,953 6,328 6,687 4,610 31,117 Change (%) 5.1 0.6 2.0 1.3 2.8 2.3 Operating profit (€ million) 2023 1,237 1,691 731 1,213 644 5,516 2024 1,269 1,696 963 1,423 597 5,948 Underlying operating profit (€ million) 2023 1,179 1,381 763 1,214 671 5,208 2024 1,305 1,601 1,031 1,491 672 6,100

Segment information - Geograp_2

Segment information - Geographical area (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure of operating segments [abstract]
Summary of Operating Results by Geographical Areas	3. Segment information - Geographical area Second Quarter Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2023 6,699 5,700 3,340 15,739 2024 6,732 5,924 3,435 16,091 Change (%) 0.5 3.9 2.9 2.2 First Half Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2023 13,421 10,956 6,051 30,428 2024 13,370 11,463 6,284 31,117 Change (%) (0.4) 4.6 3.8 2.3

Taxation (Tables)

Taxation (Tables)	6 Months Ended
	Jun. 30, 2024
Income taxes paid (refund) [abstract]
Summary of Tax Effects of Components of Other Comprehensive Income	Tax effects of components of other comprehensive income were as follows: First half 2024 2023 € million Before tax Tax (charge)/credit After tax Before tax Tax (charge)/credit After tax Gains/(losses) on: Equity instruments at fair value through other comprehensive income 31 – 31 (34) – (34) Cash flow hedges 63 (5) 58 (20) (2) (22) Remeasurements of defined benefit pension plans 242 (41) 201 (90) 43 (47) Currency retranslation gains/(losses) 772 (16) 756 (535) (20) (555) Other comprehensive income 1,108 (62) 1,046 (679) 21 (658)

Earnings per share (Tables)

Earnings per share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings per share [abstract]
Schedule of Computation of Earnings Per Share and Summary of Movements in Shares	Earnings per share for total operations for the six months were calculated as follows: First Half 2024 2023 EPS – Basic Net profit attributable to shareholders’ equity (€ million) 3,701 3,548 Average number of shares (millions of share units) 2,499.9 2,523.9 EPS – basic (€) 1.48 1.41 EPS – Diluted Net profit attributable to shareholders’ equity (€ million) 3,701 3,548 Adjusted average number of shares (millions of share units) 2,511.0 2,536.8 EPS – diluted (€) 1.47 1.40 During the period the following movements in shares have taken place: Millions Number of shares at 31 December 2023 (net of treasury shares) 2,499.0 Shares repurchased under the share buyback programme (7.3) Net movements in shares under incentive schemes 3.7 Number of shares at 30 June 2024 (net of treasury shares) 2,495.4

Acquisitions and disposals (Tab

Acquisitions and disposals (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure of detailed information about business combination [abstract]
Disclosure of Detailed Information about Deal Completion and Acquired Business	In the first half of 2024, the Group completed the following business acquisitions and disposals: Deal completion date Acquired/disposed business 1 February 2024 Acquired 91.88% of K18, a U.S. based premium hair care brand. The acquisition complements Unilever’s existing Beauty and Wellbeing portfolio, with a range of high-quality, hair care products. 1 June 2024 Sold Elida Beauty to Yellow Wood Partners LLC. Elida Beauty comprises more than 20 beauty and personal care brands, such as Q-Tips, Caress, Timotei and TIGI.

Financial instruments (Tables)

Financial instruments (Tables)	6 Months Ended
	Jun. 30, 2024
Disclosure of detailed information about financial instruments [abstract]
Schedule of Cash Resources and Other Financial Assets	The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2024 and 2023. The Group’s cash resources and 30 June 2024 31 December 2023 30 June 2023 Current Non-current Total Current Non-current Total Current Non-current Total Cash and cash equivalents Cash at bank and in hand 3,601 – 3,601 2,862 – 2,862 2,790 – 2,790 Short-term deposits (a) 981 – 981 1,181 – 1,181 1,804 – 1,804 Other cash equivalents (b) 388 – 388 116 – 116 400 – 400 4,970 – 4,970 4,159 – 4,159 4,994 – 4,994 Other financial assets Financial assets at amortised cost (c) 835 560 1,395 961 454 1,415 727 352 1,079 Financial assets at fair value through other comprehensive income (d) 61 525 586 151 458 609 – 438 438 Financial assets at fair value through profit or loss: Derivatives 79 39 118 37 75 112 36 31 67 Other (e) 470 382 852 582 399 981 613 399 1,012 1,445 1,506 2,951 1,731 1,386 3,117 1,376 1,220 2,596 Total financial assets (f) 6,415 1,506 7,921 5,890 1,386 7,276 6,370 1,220 7,590 (a) Short-term deposits typically have maturity of up to 3 months. (b) Other cash equivalents include investments in overnight funds and marketable securities. (c) Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months excluding deposits which are part of a recognised cash management process and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposits of €212 million (31 December 2023: €227 million; 30 June 2023: €228 million). (d) Included within non-current financial assets at fair value through other comprehensive income are equity investments. (e) Other financial assets at fair value through profit or loss include money market funds, marketable securities, other capital market instruments (f) Financial assets exclude trade and other current receivables.
Summary of Fair Values of Financial Assets and Financial Liabilities	The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category. € million Fair value Carrying amount As at 30 June 2024 As at 31 December 2023 As at 30 June 2023 As at 30 June 2024 As at 31 December 2023 As at 30 June 2023 Financial assets Cash and cash equivalents 4,970 4,159 4,994 4,970 4,159 4,994 Financial assets at amortised cost 1,395 1,415 1,079 1,395 1,415 1,079 Financial assets at fair value through other comprehensive income 586 609 438 586 609 438 Financial assets at fair value through profit and loss: Derivatives 118 112 67 118 112 67 Other 852 981 1,012 852 981 1,012 7,921 7,276 7,590 7,921 7,276 7,590 Financial liabilities Bank loans and overdrafts (460) (506) (606) (460) (506) (606) Bonds and other loans (27,836) (26,112) (26,265) (28,729) (26,692) (27,599) Lease liabilities (1,358) (1,395) (1,428) (1,358) (1,395) (1,428) Derivatives (537) (494) (618) (537) (494) (618) Other financial liabilities (570) (535) (457) (570) (535) (457) (30,761) (29,042) (29,374) (31,654) (29,622) (30,708)
Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category	€ million As at 30 June 2024 As at 31 December 2023 As at 30 June 2023 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets at fair value Financial assets at fair value through other comprehensive income 70 4 512 163 4 442 14 3 421 Financial assets at fair value through profit or loss: Derivatives (a) – 192 – – 149 – – 142 – Other 470 – 382 582 – 399 613 – 399 Liabilities at fair value Derivatives (b) – (586) – – (559) – – (718) – Contingent consideration – – (8) – – (157) – – (123) (a) Includes €74 million (31 December 2023: €37 million; 30 June 2023: €75 million) derivatives, reported within trade receivables, that hedge trading activities. (b) Includes €(49) million (31 December 2023: €(65) million; 30 June 2023: €(100) million) derivatives, reported within trade creditors, that hedge trading activities.

Dividends (Tables)

Dividends (Tables)	6 Months Ended
	Jun. 30, 2024
Dividends [Abstract]
Summary of Dividends on Ordinary Capital	The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date: Per Unilever PLC ordinary share (traded on the London Stock Exchange): £0.3696 Per Unilever PLC ordinary share (traded on Euronext in Amsterdam): €0.4396 Per Unilever PLC American Depositary Receipt: US$0.4773
Summary of Quarterly Dividend Calendar	The quarterly dividend calendar for the remainder of 2024 will be as follows: Announcement Date Ex-Dividend Date Record Date Payment Date Q2 2024 Dividend 25 July 2024 08 August 2024 09 August 2024 06 September 2024 Q3 2024 Dividend 24 October 2024 07 November 2024 08 November 2024 06 December 2024

Segment information - Busines_3

Segment information - Business Groups (Details) - EUR (€) € in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of operating segments [line items]
Revenue	€ 16,091	€ 15,739	€ 31,117	€ 30,428
Percentage Of Turnover Growth	2.20%		2.30%
Profit (loss) from operating activities			€ 5,948	5,516
Underlying Operating Profit			6,100	5,208
Beauty & Wellbeing
Disclosure of operating segments [line items]
Revenue	€ 3,343	3,143	€ 6,539	6,225
Percentage Of Turnover Growth	6.30%		5.10%
Profit (loss) from operating activities			€ 1,269	1,237
Underlying Operating Profit			1,305	1,179
Personal Care
Disclosure of operating segments [line items]
Revenue	€ 3,531	3,519	€ 6,953	6,911
Percentage Of Turnover Growth	0.30%		0.60%
Profit (loss) from operating activities			€ 1,696	1,691
Underlying Operating Profit			1,601	1,381
Home Care
Disclosure of operating segments [line items]
Revenue	€ 3,113	3,057	€ 6,328	6,205
Percentage Of Turnover Growth	1.80%		2%
Profit (loss) from operating activities			€ 963	731
Underlying Operating Profit			1,031	763
Nutrition
Disclosure of operating segments [line items]
Revenue	€ 3,289	3,260	€ 6,687	6,601
Percentage Of Turnover Growth	0.90%		1.30%
Profit (loss) from operating activities			€ 1,423	1,213
Underlying Operating Profit			1,491	1,214
Ice Cream
Disclosure of operating segments [line items]
Revenue	€ 2,815	€ 2,760	€ 4,610	4,486
Percentage Of Turnover Growth	2%		2.80%
Profit (loss) from operating activities			€ 597	644
Underlying Operating Profit			€ 672	€ 671

Segment information - Geograp_3

Segment information - Geographical area (Details) - EUR (€) € in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of operating segments [line items]
Revenue	€ 16,091	€ 15,739	€ 31,117	€ 30,428
Percentage Of Turnover Growth	2.20%		2.30%
Asia Pacific Africa
Disclosure of operating segments [line items]
Revenue	€ 6,732	6,699	€ 13,370	13,421
Percentage Of Turnover Growth	0.50%		(0.40%)
The Americas
Disclosure of operating segments [line items]
Revenue	€ 5,924	5,700	€ 11,463	10,956
Percentage Of Turnover Growth	3.90%		4.60%
Europe
Disclosure of operating segments [line items]
Revenue	€ 3,435	€ 3,340	€ 6,284	€ 6,051
Percentage Of Turnover Growth	2.90%		3.80%

Taxation - Narrative (Details)

Taxation - Narrative (Details)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Income taxes paid (refund) [abstract]
Average effective tax rate (in percent)	28.60%	26.90%

Taxation - Summary of Tax Effec

Taxation - Summary of Tax Effects of Components of Other Comprehensive Income (Details) - EUR (€) € in Millions		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Before tax
Equity instruments at fair value through other comprehensive income		€ 31	€ (34)
Cash flow hedges		63	(20)
Remeasurements of defined benefit pension plans		242	(90)
Currency retranslation gains/(losses)		772	(535)
Other comprehensive income		1,108	(679)
Tax (charge)/credit
Equity instruments at fair value through other comprehensive income		0	0
Cash flow hedges		(5)	(2)
Remeasurements of defined benefit pension plans		(41)	43
Currency retranslation gains/(losses)		(16)	(20)
Other comprehensive income		(62)	21
After tax
Equity instruments at fair value through other comprehensive income		31	(34)
Cash flow hedges		58	(22)
Remeasurements of defined benefit pension plans		201	(47)
Currency retranslation gains/(losses)	[1]	756	(555)
Other comprehensive income		€ 1,046	€ (658)
[1]2024 includes a hyperinflation adjustment of €680 million (2023: €247 million) in relation to Argentina and Turkey.

Earnings per share - Schedule o

Earnings per share - Schedule of Computation of Earnings Per Share (Details) - EUR (€) € / shares in Units, € in Millions, shares in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
EPS – Basic
Net profit attributable to shareholders’ equity (€ million)	€ 3,701	€ 3,548
Average number of shares (in millions of shares)	2,499.9	2,523.9
EPS - basic (in euros per share)	€ 1.48	€ 1.41
EPS – Diluted
Net profit attributable to shareholders’ equity (€ million)	€ 3,701	€ 3,548
Diluted average number of shares (in millions of shares)	2,511	2,536.8
EPS - diluted (in euros per share)	€ 1.47	€ 1.40

Earnings per share - Summary of

Earnings per share - Summary of Movements in Shares (Details) shares in Millions	6 Months Ended
	Jun. 30, 2024 shares
Reconciliation of number of shares outstanding [abstract]
Number of shares outstanding at beginning of period (in shares)	2,499
Shares repurchased under the share buyback programme (in shares)	(7.3)
Net movements in shares under incentive schemes (in shares)	3.7
Number of shares outstanding at end of period (in shares)	2,495.4

Acquisitions and disposals - Di

Acquisitions and disposals - Disclosure of Detailed Information about Deal Completion and Acquired Business (Details) - brand	Jun. 01, 2024	Feb. 01, 2024
Elida Beauty
Disclosure of detailed information about business combination [line items]
Number of brands	20
K18
Disclosure of detailed information about business combination [line items]
Percentage of voting equity interests acquired		91.88%

Acquisitions and disposals - Na

Acquisitions and disposals - Narrative (Details) - Elida Beauty € in Millions	Jun. 01, 2024 EUR (€)
Disclosure of analysis of single amount of discontinued operations [line items]
Consideration received	€ 588
Gain on disposal of Elida Beauty	€ 151

Share buyback (Details)

Share buyback (Details) - EUR (€) € in Millions				6 Months Ended
		May 17, 2024	Feb. 08, 2024	Jun. 30, 2024	Jun. 30, 2023
Disclosure of reserves within equity [line items]
Share buyback program, authorized amount		€ 850
Number of shares acquired (in shares)				7,315,036
Repurchase of shares	[1]			€ (375)	€ (753)
Other reserves
Disclosure of reserves within equity [line items]
Repurchase of shares	[1]			€ (375)	€ (753)
Top of range
Disclosure of reserves within equity [line items]
Share buyback program, authorized amount			€ 1,500
[1]Repurchase of shares reflects the cost of acquiring ordinary shares as part of the share buyback program announced on 10 February 2022 and 8 February 2024.

Financial instruments - Schedul

Financial instruments - Schedule of Cash Resources and Other Financial Assets (Details) - EUR (€) € in Millions	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Cash and cash equivalents, current
Cash at bank and in hand	€ 3,601	€ 2,862	€ 2,790
Short-term deposits	981	1,181	1,804
Other cash equivalents	388	116	400
Cash and cash equivalents	4,970	4,159	4,994
Other financial assets, current
Financial assets at amortised cost	835	961	727
Financial assets at fair value through other comprehensive income	61	151	0
Other financial assets	1,445	1,731	1,376
Current financial assets	6,415	5,890	6,370
Cash and cash equivalents, non-current
Cash at bank and in hand	0	0	0
Short-term deposits	0	0	0
Other cash equivalents	0	0	0
Cash and cash equivalents	0	0	0
Other financial assets, non-current
Financial assets at amortised cost	560	454	352
Financial assets at fair value through other comprehensive income	525	458	438
Other financial assets	1,506	1,386	1,220
Non-current financial assets	1,506	1,386	1,220
Cash and cash equivalents, total
Cash at bank and in hand	3,601	2,862	2,790
Short-term deposits	981	1,181	1,804
Other cash equivalents	388	116	400
Cash and cash equivalents	4,970	4,159	4,994
Other financial assets, total
Financial assets at amortised cost	1,395	1,415	1,079
Financial assets at fair value through other comprehensive income	586	609	438
Other financial assets	2,951	3,117	2,596
Financial assets	7,921	7,276	7,590
Financial assets at amortised cost	560	454	352
Judicial deposits
Other financial assets, non-current
Financial assets at amortised cost	212	227	228
Other financial assets, total
Financial assets at amortised cost	212	227	228
Derivatives
Other financial assets, current
Financial assets at fair value through profit or loss	79	37	36
Other financial assets, non-current
Financial assets at fair value through profit or loss	39	75	31
Other financial assets, total
Financial assets at fair value through profit or loss	118	112	67
Other
Other financial assets, current
Financial assets at fair value through profit or loss	470	582	613
Other financial assets, non-current
Financial assets at fair value through profit or loss	382	399	399
Other financial assets, total
Financial assets at fair value through profit or loss	€ 852	€ 981	€ 1,012

Financial instruments - Summary

Financial instruments - Summary of Fair Values of Financial Assets and Financial Liabilities (Details) - EUR (€) € in Millions	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Financial assets
Cash and cash equivalents	€ 4,970	€ 4,159	€ 4,994
Financial assets at amortised cost	1,395	1,415	1,079
Financial assets at fair value through other comprehensive income	586	609	438
Financial assets	7,921	7,276	7,590
Derivatives
Financial assets
Financial assets at fair value through profit or loss	118	112	67
Other
Financial assets
Financial assets at fair value through profit or loss	852	981	1,012
Fair value
Financial assets
Cash and cash equivalents	4,970	4,159	4,994
Financial assets at amortised cost	1,395	1,415	1,079
Financial assets at fair value through other comprehensive income	586	609	438
Financial assets	7,921	7,276	7,590
Financial liabilities
Bank loans and overdrafts	(460)	(506)	(606)
Bonds and other loans	(27,836)	(26,112)	(26,265)
Lease liabilities	(1,358)	(1,395)	(1,428)
Derivatives	(537)	(494)	(618)
Other financial liabilities	(570)	(535)	(457)
Financial liabilities	(30,761)	(29,042)	(29,374)
Fair value | Derivatives
Financial assets
Financial assets at fair value through profit or loss	118	112	67
Fair value | Other
Financial assets
Financial assets at fair value through profit or loss	852	981	1,012
Carrying amount
Financial assets
Cash and cash equivalents	4,970	4,159	4,994
Financial assets at amortised cost	1,395	1,415	1,079
Financial assets at fair value through other comprehensive income	586	609	438
Financial assets	7,921	7,276	7,590
Financial liabilities
Bank loans and overdrafts	(460)	(506)	(606)
Bonds and other loans	(28,729)	(26,692)	(27,599)
Lease liabilities	(1,358)	(1,395)	(1,428)
Derivatives	(537)	(494)	(618)
Other financial liabilities	(570)	(535)	(457)
Financial liabilities	(31,654)	(29,622)	(30,708)
Carrying amount | Derivatives
Financial assets
Financial assets at fair value through profit or loss	118	112	67
Carrying amount | Other
Financial assets
Financial assets at fair value through profit or loss	€ 852	€ 981	€ 1,012

Financial instruments - Summa_2

Financial instruments - Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category (Details) - EUR (€) € in Millions	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Assets at fair value
Financial assets at fair value through other comprehensive income	€ 586	€ 609	€ 438
Derivatives
Financial assets at fair value through profit and loss:
Other	118	112	67
Other
Financial assets at fair value through profit and loss:
Other	852	981	1,012
Fair value
Assets at fair value
Financial assets at fair value through other comprehensive income	586	609	438
Liabilities at fair value
Derivatives financial assets, reported within trade receivables	74	37	75
Derivatives financial liabilities, reported within trade creditors	(49)	(65)	(100)
Fair value | Derivatives
Financial assets at fair value through profit and loss:
Other	118	112	67
Fair value | Other
Financial assets at fair value through profit and loss:
Other	852	981	1,012
Fair value | Level 1
Assets at fair value
Financial assets at fair value through other comprehensive income	70	163	14
Fair value | Level 1 | Derivatives
Liabilities at fair value
Derivatives	0	0	0
Fair value | Level 1 | Financial liabilities at fair value
Liabilities at fair value
Contingent consideration	0	0	0
Fair value | Level 1 | Derivatives
Financial assets at fair value through profit and loss:
Derivatives	0	0	0
Fair value | Level 1 | Other
Financial assets at fair value through profit and loss:
Other	470	582	613
Fair value | Level 2
Assets at fair value
Financial assets at fair value through other comprehensive income	4	4	3
Fair value | Level 2 | Derivatives
Liabilities at fair value
Derivatives	(586)	(559)	(718)
Fair value | Level 2 | Financial liabilities at fair value
Liabilities at fair value
Contingent consideration	0	0	0
Fair value | Level 2 | Derivatives
Financial assets at fair value through profit and loss:
Derivatives	192	149	142
Fair value | Level 2 | Other
Financial assets at fair value through profit and loss:
Other	0	0	0
Fair value | Level 3
Assets at fair value
Financial assets at fair value through other comprehensive income	512	442	421
Fair value | Level 3 | Derivatives
Liabilities at fair value
Derivatives	0	0	0
Fair value | Level 3 | Financial liabilities at fair value
Liabilities at fair value
Contingent consideration	(8)	(157)	(123)
Fair value | Level 3 | Derivatives
Financial assets at fair value through profit and loss:
Derivatives	0	0	0
Fair value | Level 3 | Other
Financial assets at fair value through profit and loss:
Other	€ 382	€ 399	€ 399

Dividends - Summary of Dividend

Dividends - Summary of Dividends on Ordinary Capital (Details) - 3 months ended Jun. 30, 2024 - Unilever PLC	£ / shares	€ / shares	$ / shares
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | (per share)	£ 0.3696	€ 0.4396
Per Unilever PLC ordinary share | Traded on the London Stock Exchange
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | £ / shares	£ 0.3696
Per Unilever PLC ordinary share | Traded on Euronext in Amsterdam
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | € / shares		€ 0.4396
Per Unilever PLC American Depositary Receipt
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | $ / shares			$ 0.4773

Dividends - Narrative (Details)

Dividends - Narrative (Details) - 3 months ended Jun. 30, 2024	£ / shares	€ / shares
Unilever PLC
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | (per share)	£ 0.3696	€ 0.4396